BR0109573A - Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo - Google Patents

Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo

Info

Publication number
BR0109573A
BR0109573A BR0109573-0A BR0109573A BR0109573A BR 0109573 A BR0109573 A BR 0109573A BR 0109573 A BR0109573 A BR 0109573A BR 0109573 A BR0109573 A BR 0109573A
Authority
BR
Brazil
Prior art keywords
pharmacologically acceptable
compound
acceptable salt
prodrug
agent
Prior art date
Application number
BR0109573-0A
Other languages
English (en)
Inventor
Takuya Uchida
Toshiyuki Konosu
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0109573A publication Critical patent/BR0109573A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSTO OU UMA PRó-DROGA OU UM SAL FARMACOLOGICAMENTE ACEITáVEL DO MESMO, AGENTE, COMPOSIçãO FARMACêUTICA, E, USO DE UM COMPOSTO OU UMA PRó-DROGA OU UM SAL FARMACOLOGICAMENTE ACEITáVEL DO MESMO". Compostos de fórmula geral (1) ou suas pró-drogas ou seus sais farmacologicamente aceitáveis, exibindo excelente atividade antimicótica: (I) na qual Ar^ 1^ é fenila ou semelhante; Ar^ 2^ é fenileno ou semelhante; X é enxofre ou metileno; R^ 1^ é hidrogênio OU C~ 1-3~-alquila; R^ 2^ é hidrogênio ou C~ 1-3~-alquila; e R^ 3^ é C~ 6-10~-arila opcionalmente substituída ou semelhante.
BR0109573-0A 2000-03-27 2001-03-27 Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo BR0109573A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000086943 2000-03-27
PCT/JP2001/002443 WO2001072743A1 (fr) 2000-03-27 2001-03-27 Composes triazoles possedant une liaison amide

Publications (1)

Publication Number Publication Date
BR0109573A true BR0109573A (pt) 2003-01-28

Family

ID=18603035

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109573-0A BR0109573A (pt) 2000-03-27 2001-03-27 Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo

Country Status (22)

Country Link
US (1) US6653330B2 (pt)
EP (1) EP1284267B1 (pt)
KR (1) KR20020083530A (pt)
CN (1) CN1432014A (pt)
AT (1) ATE284884T1 (pt)
AU (2) AU2001242798B2 (pt)
BR (1) BR0109573A (pt)
CA (1) CA2404701A1 (pt)
CZ (1) CZ20023209A3 (pt)
DE (1) DE60107836D1 (pt)
DK (1) DK1284267T3 (pt)
HU (1) HUP0300573A2 (pt)
IL (1) IL151880A0 (pt)
MX (1) MXPA02009673A (pt)
NO (1) NO20024615L (pt)
NZ (1) NZ521603A (pt)
PL (1) PL357306A1 (pt)
PT (1) PT1284267E (pt)
RU (1) RU2232761C2 (pt)
TW (1) TW591024B (pt)
WO (1) WO2001072743A1 (pt)
ZA (1) ZA200207710B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002215213A1 (en) * 2000-11-16 2002-05-27 Sankyo Company Limited Carbamoyl-bearing triazole fungicides
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
WO2003068142A2 (en) * 2002-02-12 2003-08-21 Fdc Limited 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents
WO2004026862A1 (ja) * 2002-09-20 2004-04-01 Sankyo Company, Limited 水溶性トリアゾール化合物
CA2528493C (en) * 2003-06-06 2009-01-20 Sankyo Company Limited Medicinal composition containing triazole compound
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1151138C (zh) * 1995-04-06 2004-05-26 三共株式会社 三唑抗真菌剂
JP3622882B2 (ja) * 1996-10-04 2005-02-23 三共株式会社 トリアゾール誘導体を含有する医薬
JPH10279567A (ja) 1997-02-04 1998-10-20 Sankyo Co Ltd トリアゾール誘導体
JPH1180135A (ja) 1997-07-08 1999-03-26 Sankyo Co Ltd 抗真菌トリアゾール化合物
AU7937998A (en) * 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds

Also Published As

Publication number Publication date
DK1284267T3 (da) 2005-01-24
NZ521603A (en) 2003-10-31
EP1284267A1 (en) 2003-02-19
DE60107836D1 (de) 2005-01-20
US6653330B2 (en) 2003-11-25
CA2404701A1 (en) 2002-09-26
AU4279801A (en) 2001-10-08
ATE284884T1 (de) 2005-01-15
TW591024B (en) 2004-06-11
AU2001242798B2 (en) 2004-02-26
RU2232761C2 (ru) 2004-07-20
NO20024615D0 (no) 2002-09-26
PL357306A1 (en) 2004-07-26
HUP0300573A2 (hu) 2003-08-28
KR20020083530A (ko) 2002-11-02
EP1284267B1 (en) 2004-12-15
ZA200207710B (en) 2004-01-02
IL151880A0 (en) 2003-04-10
WO2001072743A1 (fr) 2001-10-04
US20030176480A1 (en) 2003-09-18
MXPA02009673A (es) 2003-03-10
CN1432014A (zh) 2003-07-23
CZ20023209A3 (cs) 2003-01-15
PT1284267E (pt) 2005-02-28
EP1284267A4 (en) 2004-02-11
RU2002125872A (ru) 2004-01-10
NO20024615L (no) 2002-11-22

Similar Documents

Publication Publication Date Title
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
BRPI9908319B8 (pt) composto amino cíclico, composição farmacêutica, medicamento contendo um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cíclico ou um sal farmacologicamente aceitável do mesmo.
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE297203T1 (de) Antithrombotische mitteln
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DE60119894D1 (de) Piperidinverbindungen und diese enthaltenden medikamente
BR0110955A (pt) Derivados de tropano úteis para a terapia
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
DE50108674D1 (de) Verbindungen mit einer sulfonamidgruppe und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
BR0109573A (pt) Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo
HRP20060023A2 (en) Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
ATE308540T1 (de) Antithrombosemittel
PT1338596E (pt) Processos para a preparacao de agentes antibacterianos do tipo carbapenem
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
ATE293616T1 (de) 2-fluoro-(oxido-thiopyran-4-yl)benzol derivate
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
AU2001228862A1 (en) Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
HUP0002715A2 (hu) Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SANKYO COMPANY, LIMITED (JP) , SANKYO LIFETECH COM

Free format text: TRANSFERIDO DE: SANKYO COMPANY, LIMITED

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.